![Paul-Henri Lambert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul-Henri Lambert
Corporate Officer/Principal chez
Fondation Mérieux
Profil
Paul-Henri Lambert is currently the Director of the International Advanced Vaccinology Course at the University of Geneva.
He also holds the position of Director of the International Advanced Vaccinology Course at Fondation Mérieux.
Additionally, he serves as a Member of the Supervisory Board at Hookipa Biotech AG.
Previously, he worked as the Director at HOOKIPA Pharma, Inc. from 2011 to 2019.
Postes actifs de Paul-Henri Lambert
| Sociétés | Poste | Début |
|---|---|---|
Fondation Mérieux
 Fondation Mérieux Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Corporate Officer/Principal | 14/11/2013 |
University of Geneva
 University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Paul-Henri Lambert
| Sociétés | Poste | Fin |
|---|---|---|
Hookipa Biotech AG
 Hookipa Biotech AG Medical SpecialtiesHealth Technology Develops new generation prophylactic and therapeutic vaccines | Directeur/Membre du Conseil | 18/11/2024 |
| HOOA PHARPAR | Directeur/Membre du Conseil | 25/04/2019 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Geneva
University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fondation Mérieux
Fondation Mérieux Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Develops new generation prophylactic and therapeutic vaccines | Health Technology |
HOOKIPA Pharma, Inc.
 HOOKIPA Pharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers | Health Technology |
